Skyrizi® (risankizumab-rzaa)
for Arthritis Psoriatic

Skyrizi (risankizumab) is a biologic injection that blocks IL-23 to reduce inflammation and treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease. As an interleukin-23 antagonist, it helps improve skin, joint, and gastrointestinal symptoms.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Psoriatic